Stock Markets
Daily Stock Markets News

Sector Leaders Flash Buy, Sell And Take Profit Signals On Their Charts


The IBD Sector Leaders screen, which spots leaders in IBD’s 33 sectors, remains light in numbers. Three are of note as their charts flash telling signals.




X



Sector leader Tecnoglass (TGLS) fell below the 10-week moving average in heavy volume this past week and remains below it. This made for a sell signal, breaking support after the stock rallied from a successful breakout in November. Shares also made multiple tests of the 10-week line before breaking that level.

Shares fell after first-quarter earnings came out May 4. Sales grew 51% to $202.6 million while earnings per share of $1.08 were up 104%. Tecnoglass fell again on May 17 after news of a secondary offering of 2 million shares by Energy Holding at $43 each, which was lower than the prior day’s closing price.

Despite the weak chart, a strong growth record of sales and earnings has earned the stock a perfect EPS Rating of 99. The Colombia-based company makes architectural glass, windows and aluminum products for residential and commercial buildings.

Sector Leaders Dynatrace, Lantheus

Dynatrace (DT) is still in a buy range that goes up to 50.50. On May 18, shares broke out of a cup base at 48.10 on strong earnings. This IBD Sector Leader boasts a perfect Composite Rating and EPS Rating.

Sales of $314.5 million showed a 25% increase in the March-ended quarter, while earnings per share of 31 cents were up an impressive 82%. The Waltham, Mass., company makes software automation tools for business IT processes.

Lantheus (LNTH) is another IBD Sector Leader that has performed well after a breakout. It may be time to take profits on the stock as it hovers in the 20%-25% profit zone.

The stock broke out of a cup with handle in March at a buy point of 75.20, according to IBD MarketSmith.

It gapped up in heavy volume Feb. 23 following a surge in fourth-quarter earnings, a move that put the stock closer to its buy point.

The North Billerica, Mass., company makes diagnostics, targeted therapeutics and AI-enabled imaging platforms used by clinics.

It has a perfect Composite Rating of 99 and Relative Strength Rating of 97. For the first quarter, sales of $300.8 million rose 44% while earnings per share of $1.47 were up 52%.

Please follow VRamakrishnan on Twitter for more news on the stock market today.

YOU MAY ALSO LIKE:

Top Growth Stocks To Buy And Watch

Learn How To Time The Market With IBD’s ETF Market Strategy

Find The Best Long-Term Investments With IBD Long-Term Leaders

MarketSmith: Research, Charts, Data And Coaching All In One Place





Read More: Sector Leaders Flash Buy, Sell And Take Profit Signals On Their Charts

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.